Unilens Vision Inc. Upgrades To OTCQX® Marketplace

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LARGO, FL and NEW YORK, NY--(Marketwired - September 25, 2014) - Unilens Vision Inc. (OTCQX: UVIC) ("Unilens"), which develops, licenses, manufactures, distributes and markets specialty contact lenses, and OTC Markets Group Inc. (OTCQX: OTCM), operator of the OTCQX, OTCQB® and OTC Pink® financial marketplaces, today announced that Unilens' common stock has been approved to trade on OTCQX®, the best marketplace within OTC Markets Group for established U.S. and global companies. Unilens' common stock begins trading today, September 25, 2014, on OTCQX under the symbol "UVIC." U.S. investors can find current financial disclosures and Real-Time Level 2 quotes for Unilens Vision at www.otcmarkets.com.

"We are very pleased to upgrade to the OTCQX marketplace," stated Michael Pecora, President and Chief Executive Officer of Unilens Vision Inc. "The high standards of the OTCQX marketplace underscores our emphasis on financial transparency, robust communication with investors and shareholders, and our commitment to making our stock as accessible as possible to the investment community through increased visibility and enhanced market-making support."

"We are excited to welcome Unilens Vision to OTCQX," commented R. Cromwell Coulson, President and Chief Executive Officer of OTC Markets Group. "OTCQX provides a world-class home for companies such as Unilens that are looking for alternatives to the traditional exchange listing model. The addition of companies like Unilens to OTCQX demonstrates the dramatic increase in profile the marketplace has experienced since inception."

The OTCQX marketplace is for established, investor-focused U.S. and global companies. To qualify for OTCQX, companies must meet high financial standards, demonstrate compliance with U.S. securities laws, be current in their disclosures, and be sponsored by a professional third-party advisor. Designed for investor-focused companies, OTCQX ensures that investors and brokers have the quality of information necessary to intelligently analyze, value, and trade their securities.

About OTC Markets Group Inc.

OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through its OTC Link® ATS, it directly links a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. OTC Markets Group organizes these securities into marketplaces to better inform investors regarding opportunities and risks - OTCQX®, The Best Marketplace; OTCQB®, The Venture Marketplace; and OTC Pink®, The Open Marketplace. Its data-driven platform allows investors to easily trade through the broker of their choice at the best possible price and empowers a range of companies to improve the quality and availability of information for their investors. To learn more about OTC Markets Group's better informed and more efficient marketplaces, visit www.otcmarkets.com.

About Unilens Vision Inc. - "The Independent Eye Care Professionals' Contact Lens Company"

Established in 1989 and headquartered in Largo, Florida, Unilens Vision Inc., through its wholly-owned subsidiaries, Unilens Corp., USA and Unilens Vision Sciences Inc., develops, manufactures, distributes and markets contact lenses, primarily under the C-Vue® brand, directly to Independent Eye Care Professionals. The Company also licenses its technologies to third parties. Additional information on the Company may be accessed on the Internet at www.unilens.com. The Company's common stock is traded on the OTCQX marketplace under the symbol "UVIC".

Forward-Looking Statements

The information contained in this news release, other than historical information, consists of forward-looking statements that involve risks and uncertainties that could cause actual results to differ materially from those described in such statements. For a discussion of certain factors that could cause actual results to differ materially from those described in the forward-looking statements, please refer to the Company's most recent filings with the SEC.


For more information, please contact:

Michael Pecora
CEO
Leonard Barker
CFO
Unilens Vision Inc.
(727) 544-2531
len.barker@unilens.com

or

RJ Falkner & Company, Inc.
Investor Relations Counsel
(800) 377-9893
info@rjfalkner.com

or

Saskia Sidenfaden
OTC Markets Group
(212) 896-4428
saskia@otcmarkets.com



Help employers find you! Check out all the jobs and post your resume.

Back to news